HomeTOP STORIESARS Pharmaceuticals GAAP EPS of $0.08, revenue of $89.15M ARS Pharmaceuticals GAAP EPS of $0.08, revenue of $89.15M By rogerjudd March 20, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleDarden Restaurants reports mixed Q3 results; updates FY25 outlookNext articleWashington state mayor blows up on LGBTQ activist who says flying POW/MIA flag is a ‘political stunt’ latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
